Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma
Status:
Withdrawn
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine that systemic chemotherapy is superior to
transcatheter arterial chemoembolization in prolonging progression-free survival（PFS） in
patients with Advanced Hepatocellular Carcinoma.